and Thanks, John, good morning, everyone.
to results for adjusted comparable use to to focus year basis schedules will XXX. period commentary posted quarter our the Our prior on this a follow morning third ASC Please site supplemental on Web along. the
accounting and other ASC XXX, of per revenue integration GAAP under diluted quarter, and third to fiscal $X.XX we intangible share. These costs results amortization, the related earnings items standard reported special special acquisition include For after-tax charges.
share investments $X.XX of prior strategic as growth, products to reflect from per $X.XX per year, $X.XX over growth. accelerated and earnings well These drive Adjusted core advanced diluted guidance results revenue range expansion diluted margin XX% to of share. exceeding future as our contribution continued new
to me walk outlook. with the financial turning before P&L our revenue. let Now, Starting through
X% a X%. exceeding Voalte basis our million, consecutive X% revenue XXX $XXX expectations. was and revenue revenue it X% range just to basis. Core basis for points the exceeded currency increased guidance of a constant quarter, quarter, contributed third fiscal grew the on X% our over reported with on For third that
quarter. on increased in revenue third X% basis Domestic core a the
care We respiratory systems, continue to surgical and benefit clinical vision, multiple growth from with med-surg including across workflow double-digit solutions, bed portfolio diversification product categories, tables.
with mid-single international Overall, better stages sustainable revenue have Asia declined core to growth. stabilized growth show digit in as we Latin our operations America are commercial the and early foundation X%. Pacific and setting a for improvement of continued
Front was this primarily in EMEA and timing than in performance highlighted, expected not performance of driven the capital to John offset Care Line lower enough by business. the projects the As decline
the will X% a achieved consistent business revenue address we currency core million advanced Reported I revenue all and increased what Moving Systems. year. Support on to of with growth have basis. segments, with Starting $XXX Patient revenue X%, on constant
and quarter our communications another the across diverse growth workflow of solutions contributions with positive mobile double-digit clinical solutions and This in platform. differentiated including beds, driven and performance connected services, U.S. Voalte, was our of new portfolio by from smart
Front well as as $XXX new primarily in driven million the of resulting contribution Revenue respiratory by growth and Care. Line products of physical to care to tools. vision strong increased assessment X% double-digit Moving diagnostic certain growth in and
U.S. $XXX of Vinci growth revenue year. Lastly, by Xi accelerated and Surgical of primarily for Table prior of record increased da Surgical the Motion revenue X% million System. Integrated was placements by driven Solutions the X% flat to Core
all three over of Now, performance the expanded our P&L. XX.X% year, and businesses. driven rest across improved gross record level the XXX Adjusted reached turning margin by points of the prior to basis of a
products than offset from and more expansion impact and margin product as mix, benefit items including new Voalte Gross well as improvements. operational positive continues to inflation. Collectively, of material these raw tariffs
R&D spending of in ongoing of addition SG&A investments, the to million the programs X% reflecting emerging in was for due and markets million, to timing commitment growth. Voalte. quarter investments Adjusted $XX drive and strategic innovation $XXX to future of our key the increased primarily
the of quarter impact bottom XXX quarter $X.XX third was had the XX.X%. last The a diluted margin third tax of in improvement per compared adjusted compensation current year. had reflecting prior was year. adjusted in the The quarter XX%. operating no for share earnings an basis adjusted Our Stock-based points XX.X%, the line rate but to $X.XX increased benefit
than strong Cash a $XXX million due lower Now, prior as XX% operations timing, higher of free than year. a XXXX, flow nine of flow totaled $XX was and last cash first on million, Capital for million expenditures $XXX turning $XX million months cash basis to from to advancing project of year-to-date flow. is XX%. the result the period
the the financial $XXX end leverage, approximately our June to returned ratio of repurchases the of shareholders X.Xx, terms and debt and share we XXXX to year. In EBITDA fiscal at through sheet million dividends during have balance was and
with conclude the me the Let guidance fiscal call of portion for the year. this our of remainder
our guidance We are EPS core reaffirming revenue expectations. our raising and
of operational continued diluted for share. M&A while strong offsetting financials, QX Our $X.XX performance per us strong recent positions for dilution activity approximately
specifically we X% revenue reported So year, approximately of consumables approximately full reflecting divestiture. growth X% impact expect of currency now constant growth the the of and surgical the for
growth of contribution includes the revenue of core which expect X%, now approximately Voalte. We
surgical will consumables impact is core period quarter XXXX Voalte, our is that Excluding immaterial. Please revenue of reported revenue divestiture, fourth prior of note in on beginning revenue guidance the closure the to as XXXX. be with expected core non-core be the growth The X%.
to $XXX XXXX in change million approximately other revenue no totals $XXX is which and There approximately XXXX. now non-core million in
prior-year reminder, non-core is components the both calculated guidance current and in core growth a excluding and As period. by the
Support driven core excess U.S. in grow we on to revenue X%, a By business performance. segment, of basis, robust Systems expect now Patient by
performance expected strong project Surgical QX. to in growth of continue approximately given We core Solutions X%,
Line to And Front finally, X% in driven be growth experienced by range, the we now the expect international X% growth Care year-to-date. challenging to more
the the are We also given the immaterial an from Breathe assuming of close. anticipated timing contribution acquisition,
standpoint, expect to basis and tariffs profitability mix and adjusted points, raw costs incremental From gross inflation. a more we with XX expand margin than material offset reflecting productivity associated improvements that approximately
increase recent M&A in transactions X% We expect R&D representing XX.X% continue of sales SG&A adjusted initiatives. of to approximately to and in investment of approximately growth low-single reflecting to XX% key and digits spending sales,
a to to margin adjusted points. XX XXX expansion we result, As operating continue of expect basis
of $X.XX reflects approximately diluted a per of shares. We guidance expense, of interest, tax to count to $XX continue rate approximately of million an other range share. share a This adjusted million, XX.X including $X.XX approximately and XX% expect
remains a perspective, our This transaction-related of expenditures cash prior of now outflows flow From the million guidance and $XXX operating approximately expectations. expect of including into of cash unchanged impact $XXX million. capital flow translates free which approximately $XX cash from million flow we
period fiscal on and the we basis quarter, a to prior comparable be reported expect the increase currency revenues basis. constant on year a For fourth to X%
positive approximately increase a contribution from international. to revenue core expect We including X%,
core revenue consumables this for adjusts guidance QX Our divestiture. surgical
business U.S. As Line highlighted, in we due previously year the Monarch comparisons the Front by we’ve expect a prior to the decline launch. also driven Care challenging
compensation. please significant per $X.XX of execution last items, a recent tax M&A, we dilution share. fourth special offsetting Also, that adjusted related to benefit operational excluding per stock-based we year’s quarter recorded recall diluted of strong $X.XX With expect diluted $X.XX to share executive from in earnings,
Thank you.
Now, over back John. I’ll the to turn call